Touchdown Neurotech is revolutionising neuromodulation market access for North American companies in Europe.
Combining over 25 years of knowledge, we know exactly what it takes to turn innovative healthcare and wellness products into commercially exciting opportunities.
Were dedicated to serving select North American neurotechnology and neuromodulation companies to introduce and build their commercial footprint in the UK, Europe, and other international territories.
We believe in taking actionable responsibility for the success of your product outside of the United States.
Our mission is to change what we see as an outdated and ineffective market access service. Our founders have spent the last 10 years working for start-up and scale-up organisations, being accountable for the commercial success of multiple neuromodulation devices.
We have seen first-hand how frustrating it can be working with ineffective agencies when boots on the ground and individuals acting on executing the work are what is required.
Partnering with Touchdown Neurotech gives you immediate access to our founders and their network of neurotech professionals, seamlessly extending your core team and allowing you to quickly and effectively expand into new key territories.
We understand how hard commercialising medical technologies can be, so let Touchdown Neurotech be your guide and executor to de-risk the process and allow you to achieve commercial success.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2024
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Touchdown Neurotech founded?
Touchdown Neurotech was founded in 2024.
What industry is Touchdown Neurotech in?
Touchdown Neurotech operates in Business Consulting and Services. Find similar Business Consulting and Services investors on gritt.io.
Where is Touchdown Neurotech based?
Touchdown Neurotech is headquartered in London, United Kingdom.
Find investors for your startup like Touchdown Neurotech
Gritt sends AI-personalised outreach to each investor — from your Gmail
